Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Jan;18(3):183-92.
doi: 10.1007/BF00767766.

Large scale transient expression with COS cells

Affiliations

Large scale transient expression with COS cells

H D Blasey et al. Cytotechnology. 1995 Jan.

Abstract

We demonstrate here that transient expression with COS cells can be performed at the one litre scale for a period of more than 10 days. Cells grown in T225 flasks were transfected by electroporation, transferred into spinners, and then grown either in suspension or on microcarriers. A daily medium change significantly extented culture life and production time, compared with standard protocols.Concentrations of the product, the secreted fusion protein CD40-Fc, were comparable in microcarrier and suspension culture. Cultures were started in fetal calf serum containing medium and the subsequent production process was performed in a low protein serum free medium which allowed easy downstream processing. 10 litres of supernatant, collected from one transfected batch of cells, yielded 30 mg of purified and biologically active protein.In addition to developing a simplified protocol for generation of cells we also reduced the material (DNA, cuvettes) required for electroporation. Our results show that scale up of transient expression to the litre scale can be successfully acieved. This provides a new tool to generate milligram quantities of protein within weeks of gene cloning.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Natl Cancer Inst. 1951 Feb;11(4):773-95 - PubMed
    1. Cytotechnology. 1993;13(1):51-3 - PubMed
    1. Biotechnol Prog. 1995 Jan-Feb;11(1):1-13 - PubMed
    1. J Immunol Methods. 1983 Jan 28;56(2):221-34 - PubMed
    1. Methods Enzymol. 1987;152:684-704 - PubMed

LinkOut - more resources